Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rhonda Farnum currently holds 251,449 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rhonda Farnum has been a net seller of TBPH stock. They have purchased $0 and sold $868.9K worth of shares.
Rhonda Farnum's most recent insider trade was on Apr 1, 2026, when they sold 18,750 shares at $0.00 per share.
Rhonda Farnum serves as Executive at Theravance Biopharma, Inc. (TBPH). They have executed 30 insider transactions totaling $868.9K over their tenure at the company.
Rhonda Farnum holds the position of Executive at Theravance Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Rhonda Farnum has shown a selling trading pattern, with $0 in total purchases and $868.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Rhonda Farnum was on Dec 3, 2025, when they sold $291.3K worth of TBPH shares. This transaction involved 15,534 shares at $18.75 per share.
Rhonda Farnum currently owns 251,449 shares of Theravance Biopharma, Inc. (TBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rhonda Farnum's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rhonda Farnum has 30 Form 4 filings on record as an insider at Theravance Biopharma, Inc..
Set alerts for Rhonda Farnum and 40,000+ other insiders.